Equity Capital Markets

Company · CIK 1661460

Poseida Therapeutics, Inc.

CIK1661460 (SEC EDGAR)
Industry (SIC)2836 — Biological Products, (No Diagnostic Substances)
Incorporated inDE
Business addressCA
Listedno ticker on SEC record today
First annual or quarterly report2020-08-20

Offerings

5 registrations
RegistrationLabel and statusFirst filedLast eventFilings
333-278559
ShelfEffective
 2024-04-082025-01-103
333-281248
ShelfEffective
 2024-08-052025-01-103
333-258804
ShelfEffective
 2021-08-132022-08-044
333-239321
IPOFinal prospectus
 2020-06-192020-07-105
333-229135
First-time registrationWithdrawn
 2019-01-042019-04-223

Filings

20
FiledFilingRegistrationAccession
2025-01-10EFFECTDeclared effective 333-2812489999999995-25-000073
2025-01-10EFFECTDeclared effective 333-2785599999999995-25-000071
2024-08-14EFFECTDeclared effective 333-2812489999999995-24-002530
2024-08-05S-3Shelf registered 333-2812480001193125-24-193971
2024-05-03EFFECTDeclared effective 333-2785599999999995-24-001373
2024-04-08S-3Shelf registered 333-2785590001193125-24-089705
2022-08-04424B5Shelf takedown 333-2588040001193125-22-212618
2022-08-03424B5Shelf takedown 333-2588040001193125-22-211258
2021-08-20EFFECTDeclared effective 333-2588049999999995-21-003273
2021-08-13S-3Shelf registered 333-2588040001193125-21-246073
2020-07-10424B4Final prospectus 333-2393210001193125-20-191150
2020-07-09EFFECTDeclared effective 333-2393219999999995-20-001741
2020-07-09S-1/AAmendment 333-2393210001193125-20-190019
2020-07-06S-1/AAmendment 333-2393210001193125-20-187268
2020-06-19S-1Registration filed 333-2393210001193125-20-174164
2020-04-17DRSDraft made public 377-031330000950123-20-003445
2019-04-22RWWithdrawn 333-2291350001193125-19-113426
2019-03-04S-1/AAmendment 333-2291350001193125-19-062627
2019-01-04S-1Registration filed 333-2291350001193125-19-002428
2018-11-01DRSDraft made public 377-023460000950123-18-010440

All filings of this company · CSV